Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association

Barbara S. Wiggins, Joseph J. Saseen, Robert L. Page, Brent N. Reed, Kevin Sneed, John B. Kostis, David Lanfear, Salim Virani, Pamela B. Morris

Research output: Contribution to journalArticlepeer-review

172 Scopus citations
Original languageEnglish (US)
Pages (from-to)e468-e495
Issue number21
StatePublished - Nov 22 2016

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)


  • AHA Scientific Statements
  • anti-arrhythmic agents
  • anticoagulants
  • calcium channel blockers
  • cardiovascular disease
  • drug-related side effects and adverse reactions
  • fenofibrate/fenofibric acid derivatives
  • gemfibrozil
  • hydroxymethylglutaryl-CoA reductase inhibitors
  • immunosuppressive agents

Cite this